Go Back To Menu
United Life is a leading life sciences innovation enterprise, jointly invested by mainland researchers, Macao medical teams, and U.S. R&D teams, located in the Hengqin Guangdong-Macao In-Depth Cooperation Zone, China. As an advocate of interdisciplinary collaboration and open innovation, it has pioneered the “One Bank, Six Platforms, Six Centers” applied research system, applying cutting-edge life sciences research results to the rehabilitation management of refractory diseases. It provides clients and families with life-quality services such as cell storage, cell preparation, refractory disease rehabilitation management, sub-health recovery, and quality management for the elderly.
The applied research system of United Life was created by Nobel Prize winner Randy W. Schekman, leading an international scientific research team together with China’s top experts. It is an international life sciences R&D and application transformation platform focusing on cutting-edge research in stem cells and immune cells. Its China Placenta Resource Bank and Greater Bay Area International Cell Bank use internationally advanced sample processing and storage technologies to store various biological samples, ensuring seed sources for life sciences research and translational applications. It has built six life sciences R&D platforms: U.S. R&D Center, Hengqin R&D Center, Regenerative Medicine Joint Laboratory, Guangzhou R&D Center, Shenzhen R&D Center, and Skincare Raw Materials Innovation Institute. Among them, the Randy Joint Science Laboratory at the Hengqin R&D Center holds overall Class 10,000 and partial Class 100 cGMP certifications. The Regenerative Medicine Joint Laboratory has three approved IND pipelines and five pipelines pending IND submission. Based on the six life sciences R&D platforms, United Life has also built six life-quality delivery centers, including: Hengqin International Medical Department, Guangzhou Xinghe Medical, Shenzhen Xinghe Medical, Zhuhai Xinghe Rehabilitation Center, Cellular Anti-Aging Skin Center, and Specialty Pharmacy. After more than ten years of development, the China Placenta Resource Bank, six R&D platforms, and six delivery centers work together to form a full industry service loop from cell sourcing to basic research to translational applications, providing world-class health management services.
United Life’s core R&D and service bases are located in Guangzhou, Shenzhen, Zhuhai, and Hengqin, with branch offices established in Hong Kong, Macao, and the United States. Its business footprint covers the Greater Bay Area and extends globally. It owns nearly 20,000㎡ of scientific research and medical service facilities, with an overseas business unit serving international patients — bringing Chinese medical technologies to the world while welcoming global patients to China.
United Life holds more than 40 exclusive patents and over 100 joint patents. Its innovative 1+5+N health management methodology has shown great potential in multiple disease areas including oncology, neurological, cardiovascular, joint, ophthalmic, and pulmonary diseases. For over a decade, it has served nearly 15,000 patients with refractory diseases, bringing hope to countless patients and families.
United Life has always upheld its goal of practical outcomes, continuously expanding the boundaries of technology, and fulfilling its founding mission: Let life be free in time.
